Peter de Blank, MD, MSCE
Children's Hospital Medical Center, Cincinnati
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Peter de Blank, MD, MSCE as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:47 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06838676 · ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade GliomasNationwide Children's Hospital · recruiting · Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG, Refractory DIPG · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in diffuse midline glioma (dipg).